The International Conference on Harmonization posts a final guide entitled Quality Risk Management Q9 (R1), which has been adopted by FDA for implemen...
Federal Register notice: FDA seeks comments on an information collection extension entitled Accreditation Scheme for Conformity Assessment Program.
The agency is seeking public comment on the guidance for 60 days.
FDA says a Surmodics PMA for its SurVeil drug-coated balloon to treat peripheral artery disease is not currently approvable.
FDA publishes a final rule amending and repealing some radiological health regulations.
FDA posts a draft guidance entitled Mpox: Development of Drugs and Biological Products.
FDA asks a Florida federal court for an injunction against LGM Pharma to ensure that it no longer holds and ships adulterated drugs.
FDA releases the form FDA-483 with 11 observations from an inspection at Indias Intas Pharmaceuticals.